1.54 0.05 (3.36%)

73.72% Fall from 52W High

36,565 XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Celularity Inc - Ordinary Shares - Class A

The latest disclosure was made by Kok Thay Lim in Celularity Inc - Ordinary Shares - Class A where a trade of 652,981 Warrants (Right to Buy) done was reported to US exchanges on Jan. 24, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kok Thay Lim Ten Percent Owner 24 Jan 2025 652,981 0 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner 24 Jan 2025 535,274 0 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 24 Jan 2025 652,981 652,981 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 24 Jan 2025 652,981 0 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 24 Jan 2025 535,274 535,274 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 24 Jan 2025 535,274 0 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner 24 Jan 2025 652,981 6,335,630 - 2.1 1,351,671 Class A Common Stock
Kok Thay Lim Ten Percent Owner 24 Jan 2025 535,274 5,682,649 - 2.1 1,108,017 Class A Common Stock
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 416,459 - - Stock Option (Right to Buy)
Richard J. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 202,857 - - Stock Option (Right to Buy)
Richard J. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 67,416 - 0 Class A Common Stock
Dean C. Kehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 303,482 - 0 Class A Common Stock
Dean C. Kehler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 362,524 - - Stock Option (Right to Buy)
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 1,374,482 - 0 Class A Common Stock
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 362,524 - - Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 67,416 - 0 Class A Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 1,334,746 - - Stock Option (Right to Buy)
Diane L. Parks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 303,482 - 0 Class A Common Stock
Diane L. Parks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 84,746 362,524 - - Stock Option (Right to Buy)
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 67,416 201,723 - 0 Class A Common Stock
Richard Berman J. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 118,111 118,111 - - Stock Option Grant (Right to Buy)
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 15 Jul 2024 1,350,000 1,350,000 - - Warrants (Right to Buy)
Kyle Fletcher See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. 13 Apr 2024 20 21,085 - 4.1 82 Class A Common Stock
Robert J. Hariri Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. 13 Apr 2024 1,154 2,855,889 - 4.1 4,743 Class A Common Stock
Kyle Fletcher See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.68 per share. 15 Mar 2024 617 21,105 - 5.7 3,505 Class A Common Stock
Kok Thay Lim Ten Percent Owner Other type of transaction at price $ 0.00 per share. 13 Mar 2024 300,000 300,000 - - Warrants (Right to Buy)
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 2,937,788 2,937,788 - - Stock Option Grant (Right to Buy)
Fletcher Kyle See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 164,171 164,171 - - Stock Option Grant (Right to Buy)
Kilcoyne Adrian Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 205,213 205,213 - - Stock Option Grant (Right to Buy)
Fletcher Kyle See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 16 Feb 2024 39,571 217,228 - 0.4 17,174 Class A Common Stock
Adrian Kilcoyne Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 16 Feb 2024 52,762 1,122,238 - 0.4 22,899 Class A Common Stock
Kok Thay Lim Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Jan 2024 5,352,746 5,352,746 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.25 per share. 12 Jan 2024 21,410,983 51,473,762 - 0.2 5,331,335 Class A Common Stock
Thay Lim Kok Ten Percent Owner Other type of transaction at price $ 0.00 per share. 12 Jan 2024 6,529,818 6,529,818 - - Warrants (Right to Buy)
Thay Lim Kok Ten Percent Owner Other type of transaction at price $ 0.00 per share. 12 Jan 2024 6,529,818 0 - - Warrants (Right to Buy)
Kok Thay Lim Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Jan 2024 16,500,000 16,500,000 - - Warrants (Right to Buy)
Adrian Kilcoyne Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 875,000 1,175,000 - 0 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. 13 Apr 2023 11,540 10,148,310 - 0.7 8,241 Class A Common Stock
Kyle Fletcher See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. 13 Apr 2023 201 256,799 - 0.7 144 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.83 per share. 27 Mar 2023 2,084,854 10,159,850 - 0.8 1,739,394 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 2,084,854 2,084,854 - - Warrants (Right to Buy)
Kyle Fletcher See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. 15 Mar 2023 2,170 257,000 - 0.6 1,365 Class A Common Stock
Adrian Kilcoyne Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 300,000 300,000 - - Class A Common Stock
Kyle Fletcher See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 225,000 259,170 - - Class A Common Stock
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. 10 Feb 2023 1,071,000 1,107,145 - 0.3 299,880 Class A Common Stock
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2023 1,071,000 2,660,136 - - Stock Option (Right to Buy)
Robert J. Hariri Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.72 per share. 30 Nov 2022 10,000 8,074,996 - 1.7 17,175 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.71 per share. 29 Nov 2022 40,000 8,064,996 - 1.7 68,400 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.74 per share. 28 Nov 2022 40,000 8,024,996 - 1.7 69,600 Class A Common Stock
John Sculley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Aug 2022 768,594 0 - - Stock Option (Right to Buy)
John Sculley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. 26 Aug 2022 768,594 804,739 - 0.3 215,206 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.87 per share. 24 Aug 2022 119,073 7,984,996 - 2.9 341,740 Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Aug 2022 119,073 230,287 - - Stock Option (Right to Buy)
Robin L. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2022 250,000 250,000 - - Stock Option (Right to Buy)
Robin L. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2022 800,000 800,000 - - Stock Option (Right to Buy)
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2022 131,234 7,865,923 - - Class A Common Stock
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2022 384,801 384,801 - - Stock Option (Right to Buy)
Andrew Pecora President Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2021 2,469,282 2,469,282 - - Stock Option (Right to Buy)
Beloo Mirakhur EVP, Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Sep 2021 125,000 125,000 - - Stock Option (Right to Buy)
Robert J. Hariri Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2021 2,690,079 2,690,079 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures